Amniocentesis Needle Market By Type (100 –150 mm Needles, Larger Than 150 mm Needles and Smaller Than 100 mm Needles), By Procedure (Amniocentesis Procedures, Amnioreduction Procedures, Foetal Blood Transfusion Procedures, Amnioinfusion Procedures and Cordocentesis Procedures), By End User (Hospitals, Diagnostic Centres, Clinics and Other End Users), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Amniocentesis, commonly known as amniotic fluid test or AFT, is a form of prenatal test. Amniocentesis is used to diagnose chromosomal abnormalities and infections in the pregnancy. It can also be used to determine sex. An amniocentesis needle is used to precisely remove amniotic fluid. Amniocentesis needles are sterile and are used once. The needle tip includes a spiral etching to provide clear sight when using ultrasound. The amniocentesis needle is inserted into the amniotic sac, away from both the foetus and the placenta, to withdraw amniotic fluid. Amniocentesis is a prenatal test that is also known as an amniotic fluid test (AFT). It is used to detect chromosomal abnormalities and prenatal infections. It is also used to determine sex. Amniocentesis is the evacuation of a small volume of amniotic fluid from the sac enclosing the foetus, which contains foetal tissues. Amniotic fluid contains cells and other compounds that can provide information about the health of the foetus. An amniocentesis needle is used to precisely remove amniotic fluid. Amniocentesis needles are sterile and are used once. The spiral etching on the amniocentesis needle tip provides clear sight under ultrasound guiding. To withdraw amniotic fluid, the needle is inserted into the amniotic sac, away from both the baby and the placenta. Amniocentesis Needle Market accounted for US$ 161.03 billion in 2020 and is estimated to be US$ 205.63 billion by 2030 and is anticipated to register a CAGR of 3.0%.

COVID-19 Impact:

To care for the diseased population, the demand for medical supplies is increasing. Respiratory support equipment, such as an atomizer, a life-support machine, an oxygen generator, and a monitor, are among the most commonly utilised medical devices in primary clinical care. Furthermore, COVID-19 has resulted in a significant increase in demand for medical goods such as personal protective equipment such as masks, gloves, and protective eyeglasses. As the number of COVID-19 cases worldwide rises, so does the demand for medical supplies among healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to benefit on the rising demand for medical supplies in order to provide an appropriate and consistent supply of personal protective equipment in the market. Given these considerations, COVID -19 is projected to have significant impact on amniocentesis needle market.

Increase in the prevalence of genetic disorders

The increase in the prevalence of genetic disorders is one of the primary reasons driving market expansion. Another market growth determinant is the increased emphasis on healthcare technical improvements for the creation of new and advanced goods, as well as the rising need for less invasive surgeries. Expanding R&D capabilities, a growing pregnant population, and rising personal disposable income will all contribute to profitable market growth potential.

The amniocentesis needle market is driven by an increase in pregnancy rates, a preference for non- and minimally-invasive diagnostic procedures, high adoption and acceptance of diagnostic tests in developed markets, a high success rate of the amniocentesis procedure, and technological innovations and developments. Fetal injuries, fierce competition among existing competitors, and the high cost of the surgery are major market barriers. Furthermore, in developing and undeveloped countries, diagnostic equipment is few, and the rural populace is unaware of the amniocentesis process.

Amniocentesis Needle Market report segments the market on the basis of type, procedure, end-user and region.

On the basis of Type, the Amniocentesis Needle Market is segmented into 100 –150 mm Needles, Larger Than 150 mm Needles and Smaller Than 100 mm Needles. Based on Procedure, the market is segmented into Amniocentesis Procedures, Amnioreduction Procedures, Foetal Blood Transfusion Procedures, Amnioinfusion Procedures and Cordocentesis Procedures. Based on End-User the market is segmented into Hospitals, Diagnostic Centres, Clinics and Other End Users.

Regional Insights:

Amniocentesis Needle Market accounted for US$ 161.03 billion in 2020 and is estimated to be US$ 205.63 billion by 2030 and is anticipated to register a CAGR of 3.0%.On region the Global Amniocentesis Needle Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Over the forecast period, North America will continue to lead the global market. Factors such as rising government initiatives and an increase in the frequency of amniocentesis procedures are propelling the market in this region forward. The developed healthcare system in the United States is increasing demand for modern products, which is speeding up the expansion of amniocentesis needles with advanced technology. Furthermore, the general population in North America is concerned about genetic problems in newborns, which is driving the demand for amniocentesis procedures.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Global Amniocentesis Needle Market report based on Type, Procedure, End-User and Region.

Amniocentesis Needle Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the Amniocentesis Needle Market includes Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).

Medtronic:

Medtronic plc is a registered American-Irish medical device business based in the United States. Medtronic's operational and executive headquarters are located in Minneapolis, Minnesota, in the United States. The SharkCoreTM FNB needle's six distal cutting blades are specifically engineered to retrieve cohesive units of tissue with intact cell architecture. The needle can potentially offer superior core samples and help gastroenterologists and pathologists make more consistent and definitive diagnosis by decreasing tissue stacking and fracturing.

• Medtronic
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• BD
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• CooperSurgical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Smiths Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Medline
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cook Medical
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Laboratoire CCD
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Biopsybell
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

Related Reports: 

• Fluid Management System Market
• Polydimethylsiloxane Market
• Amniotic Membrane Market